Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectogesic after stapled haemorrhoidectomy for postoperative pain
ACTRN12611000455965Phase 4Active, not recruiting
- Sponsor
- Trent Cross
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of nitroglycerin in hemorrhoid (2 arms), sponsored by Trent Cross. Primary endpoint: Benefit of Rectogesic after stapled haemorrhoidectomy. Started Oct 2010; status: active, not recruiting.
02
Drugs
nitroglycerin
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on ACTRN12611000455965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000455965.